Dosage and administration
No more than 4 times per day, with an interval of not less than 4 hours between each use, and not more than 7 days of continuous use.
No more than 4 times per day, with an interval of not less than 4 hours between each use, and not more than 7 days of continuous use.
If you are using other drugs, please consult your physician or pharmacist before using this product. Shielded from light, sealed, stored in a cool place (not more than 20℃).
Naphazoline HCL (0.06%)
Relief of Allergic Rhinitis,
Acute Rhinitis, Chronic,Rhinitis and Inflammatory,Nasal Congestion
First remove the protective cap, before first use, press several times until liquid squirts out, then insert the nozzle into the nostril, press firmly, pull the nozzle out of the nostril before releasing, then release, close the cap for protection.
· For adults only.
· Use of this container by more than one person may spread infection.
Do not use: children, atrophic rhinitis, nasal dryness. Do not use when the character of this product changes.
When Using this product: avoid contact with eyes and mouth. If there is burning sensation, redness or
swelling at the site of application, the drug should be discontinued and the local drug should be washed off. Consult a physician if necessary.
Stop Using and ask a doctor if you have Hypertension, Coronary heart disease,
Hyperthyroidism or Allergic person.
Stop Using and ask a doctor if you have Hypertension, Coronary heart disease, Hyperthyroidism or Allergic person.
Keep out of reach of Children. In cacse of accidental ingestion, get medical help or contact a poison control center immediately.
No more than 4 times per day, with an interval of not less than 4 hours between each use, and not more than 7 days of continuous use.
If you are using other drugs, please consult your physician or pharmacist before using this product.
Shielded from light, sealed, stored in a cool place (not more than 20℃).
Water, Glycosyl Trehalose, Schizophyllan, Citrus
Reticulata (Tangerine) Fruit Extract, Benzyl
Alcohol, Polysorbate 80, Sodium Citrate, Rhamnose,
Carboxymethyl Chitosan, Phenoxyethanol, Disodium Edta, Benzoic Acid
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
| e18001c8-33ae-5f66-9cdc-a39724bd4573 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76986-001-01 | Seacall Nasal Spray. | 30 mL in 1 BOTTLE | SPRAY | 30 | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76986-001 | 76986-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NAPHAZOLINE HCL | MZ1131787D | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| N-CARBOXYMETHYLCHITOSAN | 5R88W82CC6 | IACT |
| SIZOFIRAN | 7F763NNC9X | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| RHAMNOSE | QN34XC755A | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| WATER | 059QF0KO0R | IACT |
| TANGERINE | KH3E3096OO | IACT |
| BENZOIC ACID | 8SKN0B0MIM | IACT |
| GLUCOSYL TREHALOSE | 76B4LOB2YC | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2025-10-15 | monthly-update | 2026-06-03 17:38:14 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Seacall Nasal Spray. | NASAL SPRAY | Guangdong Quadrant Ecological Technology Co., Ltd. | 1f12618b-7461-fb47-e063-6294a90af753 | 2026-01-23 | Warnings | 76986-001-01 76986-001 76986000101 490aff7a-9ed2-f2e0-e063-6394a90a38c7 1f12618b-7461-fb47-e063-6294a90af753 |
Adverse event summaries are temporarily unavailable. Other product information remains available.